Sodium Bicarbonate 8.4% 4.2 g/50 mL Injection vial

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

sodium bicarbonate, Quantity: 4.2 g

Disponible depuis:

Phebra Pty Ltd

DCI (Dénomination commune internationale):

sodium bicarbonate

forme pharmaceutique:

Injection

Composition:

Excipient Ingredients: disodium edetate; water for injections

Mode d'administration:

Intravenous

Unités en paquet:

50 mL vials - pack of 10

Type d'ordonnance:

(S1) This Schedule is intentionally blank

indications thérapeutiques:

Sodium Bicarbonate Injection is indicated as an alkalinising agent in the treatment of metabolic acidosis which may occur in many conditions including diabetes, starvation, hepatitis, cardiac arrest, shock, severe dehydration, renal insufficiency, severe diarrhoea, Addison's disease or administration of acidifying salts (e.g. excessive sodium chloride, calcium chloride, ammonium chloride). Sodium Bicarbonate Injection is also used to increase urinary pH in order to increase the solubility of certain weak acids (e.g. cystine, sulphonamides, uric acid) and in the treatment of certain intoxications (e.g. methanol, phenobarbitone, salicylates, lithium) to decrease renal absorption of the drug or to correct acidosis.

Descriptif du produit:

Visual Identification: Clear, colourless solution supplied in a 50 mL vial.; Container Type: Vial; Container Material: Glass; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Statut de autorisation:

Licence status A

Date de l'autorisation:

2017-09-20